Hormone Tx no harm after nonserous epithelial ovarian CA

April 10, 2016

(HealthDay)—For women with nonserous epithelial ovarian cancer, hormone therapy (HT) after treatment does not reduce survival, according to a study published in the May issue of Obstetrics & Gynecology.

Laura Power, M.D., from the University of Manitoba in Winnipeg, Canada, and colleagues conducted a retrospective cohort study to examine the correlation between HT after nonserous epithelial ovarian cancer and overall and disease-free survival. Women with known nonserous epithelial ovarian, fallopian tube, or primary peritoneal cancer between 1995 and 2010 who had used HT after treatment were identified.

The researchers found that 94 received HT after treatment and 263 did not. In multivariate landmark analysis and time-varying Cox regression analysis, disease-free survival was improved in HT users younger than 55 years of age (adjusted hazard ratios, 0.354 and 0.212) after adjustment for International Federation of Gynecology and Obstetrics stage and need for chemotherapy. No significant difference was seen for overall survival in this age group. For women aged 55 years and older there were no correlations for HT use and overall or disease-free survival.

"After treatment for nonserous , is not associated with decreased disease-free or overall survival," the authors write.

Explore further: Surgery, chemo best for elderly with advanced ovarian cancer

More information: Full Text (subscription or payment may be required)

Related Stories

Surgery, chemo best for elderly with advanced ovarian cancer

December 29, 2015
(HealthDay)—Primary debulking surgery and chemotherapy in an optimal timeframe is associated with the longest survival time for elderly women with advanced ovarian cancer, according to a study published in the January issue ...

Survival improving for women with ovarian cancer

May 12, 2015
(HealthDay)—Women diagnosed with ovarian cancer are now much more likely to survive the disease than they were several decades ago, according to research published online May 6 in Obstetrics & Gynecology.

Timing of hormone therapy use impacts alzheimer's risk

October 25, 2012
(HealthDay)—Use of hormone therapy (HT) within five years of menopause is associated with a reduction in the risk of Alzheimer's disease (AD), according to a study published online Oct. 24 in Neurology.

VTE risk varies by hormone therapy formulation

September 18, 2012
(HealthDay)—The risk of venous thromboembolism (VTE) in postmenopausal women differs considerably according to the formulation of hormone therapy (HT) used, with the highest VTE risk seen in users of oral estrogen-progestin ...

Novel pharmacological activity for R-ketorolac in ovarian cancer

August 4, 2015
(HealthDay)—The R-enantiomer of ketorolac is enriched in peritoneal fluids and inhibits peritoneal cell GTPase activity with administration after ovarian cancer surgery, according to a study published online June 12 in ...

Gene tests may help predict outcomes in advanced ovarian cancer

March 21, 2016
(HealthDay)—A special genetic test might help gauge outcomes for women diagnosed with ovarian cancer, a new study suggests.

Recommended for you

Hysterectomy linked to memory deficit in an animal model

December 6, 2018
By age 60, one in three American women have had a hysterectomy. Though hysterectomy is a prevalent and routine surgery, the removal of the uterus before natural menopause might actually be problematic for cognitive processes ...

Obesity intervention needed before pregnancy

December 6, 2018
New research from the University of Adelaide's Robinson Research Institute supports the need for dietary and lifestyle interventions before overweight and obese women become pregnant.

First baby born via uterus transplanted from dead donor

December 5, 2018
In a medical first, a mother who received a uterus transplant from a dead donor gave birth to a healthy baby, researchers reported Wednesday.

Researchers find evidence of prenatal environment tuning genomic imprinting

December 5, 2018
A team of researchers from the U.S., Australia and Denmark has found evidence of the prenatal environment tuning genomic imprinting. In their paper published in Proceedings of the National Academy of Sciences, the group describes ...

RSV study reveals age when infants are most vulnerable to asthma

December 5, 2018
New research suggests a maternal vaccination against RSV should be augmented with active immunisation in a child's first two years to reduce the onset of asthma.

Mediterranean diet during pregnancy associated with lower risk of accelerated growth

December 4, 2018
The Mediterranean diet is characterised by a high content of fruits, vegetables, olive oil, legumes and nuts. This healthy diet pattern has been associated with lower obesity and cardiometabolic risk in adults, but few studies ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.